# US 2025/0084375 A1 · Three-Dimensional Skin Constructs

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0084375 A1
- Document ID: US20250084375A1
- Status: Published application
- Kind: A1
- Application number: 18/830,822
- Filed: 2024-09-11
- Published: 2025-03-13
- Earliest claimed: 2023-09-12
- Assignees: NUtech Ventures
- Applicants: NUtech Ventures
- Inventors: Fanben Meng; Ruiguo Yang; Haiwei Zhai; Xiaowei Jin
- Web page: https://patentgrep.com/patent/US20250084375A1

## CPC

- C12N 5/0629: {Keratinocytes; Whole skin}
- C12N 5/0698: {Skin equivalents}
- C12N 2502/1323: Adult fibroblasts
- C12N 2503/02: Drug screening
- C12N 2513/00: 3D culture
- C12N 2533/54: Collagen; Gelatin
- C12N 2533/56: Fibrin; Thrombin
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present disclosure describes methods of generating three-dimensional skin tissue constructs comprising a basal-to-suprabasal transition.

## Claims

### Claim 1

A method of generating a three-dimensional skin tissue construct comprising a basal-to-suprabasal transition, the method comprising:
(a) depositing onto a substrate a droplet comprising one or more undifferentiated keratinocyte cells;
(b) depositing onto the substrate another droplet comprising one or more additional undifferentiated keratinocyte cells; and
(c) maintaining the undifferentiated keratinocyte cells on the substrate in a condition that promotes differentiation of undifferentiated keratinocyte cells;
wherein the droplet of (b) is deposited a predetermined distance away from the droplet of (a);
wherein undifferentiated keratinocyte cells migrate from droplets of (a) and (b), generating a basal cell layer;
wherein proliferation and differentiation of keratinocyte cells of the basal cell layer generate differentiated suprabasal keratinocyte cells and a basal-to-suprabasal transition between at least a subset of adjacent keratinocyte cells of the basal layer and differentiated suprabasal keratinocyte cells; and
wherein the extent of differentiation of keratinocyte cells and the extent of the basal-to suprabasal transition present after (c) varies based on the predetermined distance.

### Claim 2 (depends on 1)

The method of claim 1, wherein the predetermined distance is 800 to 1000 micrometers measured edge-to-edge from the droplets of (a) and (b) deposited on the substrate.

### Claim 3 (depends on 1)

The method of claim 1, wherein maintaining the undifferentiated keratinocyte cells during (c) comprises maintaining the undifferentiated keratinocyte cells in low-calcium medium.

### Claim 4 (depends on 1)

The method of claim 1, wherein the droplets of (a) and (b) each comprise a hydrogel comprising one or more undifferentiated keratinocyte cells.

### Claim 5 (depends on 1)

The method of claim 1, wherein the substrate comprises a hydrogel.

### Claim 6 (depends on 1)

The method of claim 1, wherein the substrate does not comprise a lattice structure.

### Claim 7 (depends on 2)

The method of claim 2, wherein maintaining the undifferentiated keratinocyte cells during (c) comprises maintaining the undifferentiated keratinocyte cells in low-calcium medium;
wherein the droplets of (a) and (b) each comprise a hydrogel comprising the one or more undifferentiated keratinocyte cells;
wherein the substrate comprises a hydrogel; and
wherein the substrate does not comprise a lattice structure.

### Claim 8 (depends on 1)

The method of claim 1, wherein the substrate comprises one or more human dermal fibroblast cells.

### Claim 9 (depends on 1)

The method of claim 1, wherein the substrate comprises one or more microvascular channels.

### Claim 10 (depends on 7)

The method of claim 7, wherein the substrate comprises one or more human dermal fibroblast cells.

### Claim 11 (depends on 7)

The method of claim 7, wherein the substrate comprises one or more microvascular channels.

### Claim 12 (depends on 10)

The method of claim 10, wherein the substrate comprises one or more microvascular channels.

### Claim 13 (depends on 1)

A method of testing an effect of a pharmaceutical on skin tissue, the method comprising:
(1) generating a three-dimensional skin tissue construct comprising a basal-to-suprabasal transition according to the method of claim 1;
(2) contacting the three-dimensional skin tissue construct of (1) with a pharmaceutical; and
(3) observing a change of the three-dimensional skin tissue construct after (2).

### Claim 14 (depends on 7)

A method of testing an effect of a pharmaceutical on skin tissue, the method comprising:
(1) generating a three-dimensional skin tissue construct comprising a basal-to-suprabasal transition according to the method of claim 7;
(2) contacting the three-dimensional skin tissue construct of (1) with a pharmaceutical; and
(3) observing a change of the three-dimensional skin tissue construct after (2).

### Claim 15 (depends on 12)

A method of testing an effect of a pharmaceutical on skin tissue, the method comprising:
(1) generating a three-dimensional skin tissue construct comprising a basal-to-suprabasal transition according to the method of claim 12;
(2) contacting the three-dimensional skin tissue construct of (1) with a pharmaceutical; and
(3) observing a change of the three-dimensional skin tissue construct after (2).

### Claim 16 (depends on 15)

The method of claim 15, wherein the contacting of (2) comprises delivering the pharmaceutical by one or more microvascular channels in the substrate.

### Claim 17 (depends on 1)

A method of generating a disease-state model of skin tissue, the method comprising:
(1) generating a three-dimensional skin tissue construct comprising a basal-to-suprabasal transition according to the method of claim 1; and
(2) contacting the three-dimensional skin tissue construct of (1) with an agent to alter the construct to mimic a disease state.

### Claim 18 (depends on 17)

The method of claim 17, wherein maintaining the undifferentiated keratinocyte cells during (c) comprises maintaining the undifferentiated keratinocyte cells in low-calcium medium;
wherein the droplets of (a) and (b) each comprise a hydrogel comprising the one or more undifferentiated keratinocyte cells;
wherein the substrate comprises a hydrogel; and
wherein the substrate does not comprise a lattice structure.

### Claim 19 (depends on 18)

The method of claim 18, wherein the substrate comprises one or more microvascular channels.

### Claim 20 (depends on 19)

The method of claim 19, wherein the contacting of (2) comprises delivering the agent by one or more microvascular channels in the substrate.
